Page 1,642«..1020..1,6411,6421,6431,644..1,6501,660..»

Stem Cell Therapy – Runner’s World

Posted: March 14, 2017 at 2:47 pm


Runner's World
Stem Cell Therapy
Runner's World
While PRP therapy stimulates the healing process of tissue that is already there, stem cells may create new tissue. This is why researchers and physicians think this therapy may help joint injuries caused by worn-out cartilage; in cell cultures, stem ...
$145.8 Million Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source - Global Forecasts to 2021 ...Business Wire (press release)
Has stem cell therapy helped the Boden's poster girl say her first words? Cerebral palsy patient Holly, 11, shows ...Daily Mail
Stem cell therapy for the treatment of Peyronie's disease.UroToday
CanIndia News -Medgadget (blog)
all 15 news articles »

View original post here:
Stem Cell Therapy - Runner's World

Posted in Cell Therapy | Comments Off on Stem Cell Therapy – Runner’s World

RepliCel’s autologous cell therapy candidate to treat hair loss safe in long-term study; shares ease 5% on long … – Seeking Alpha

Posted: March 14, 2017 at 2:47 pm

Thinly traded nano cap ReliCel Life Sciences (OTCQB:REPCF -5.1%) slips after it announced data from a five-year Phase 1 study assessing the safety of its autologous cell therapy for the treatment of androgenic alopecia (pattern baldness), RCH-01. The results were fine, but the timeline for the next study has apparently dampened investors' enthusiasm.

The 19-subject trial met its endpoints thereby confirming the complete safety profile of a high dose of dermal sheath cup cells, administered via injection, for patients with pattern baldness.

Although not powered for efficacy, a treatment effect was observed. The seven best responders experienced at least a 10% increase versus baseline in hair density six months after injection. At month 24, the average hair density increase in the same seven subjects was 8.3%. The top responder showed a 21% increase in hair density at month 24.

The company intends to advance RCH-01 into a Phase 2 study in 160 healthy men with mild-to-moderate pattern baldness. Dermal sheath cup cells will be isolated from a small punch biopsy taken from the back of the subject's scalp. The cells will be replicated and then reintroduced into balding areas. Participants will remain on study for ~39 months.

Read the original post:
RepliCel's autologous cell therapy candidate to treat hair loss safe in long-term study; shares ease 5% on long ... - Seeking Alpha

Posted in Cell Therapy | Comments Off on RepliCel’s autologous cell therapy candidate to treat hair loss safe in long-term study; shares ease 5% on long … – Seeking Alpha

Patient Voices: Type 2 Diabetes – New York Times

Posted: March 14, 2017 at 2:46 pm


New York Times
Patient Voices: Type 2 Diabetes
New York Times
Nearly 400 million people around the world have Type 2 diabetes, including about 28 million in the United States. Of those, as many as eight million don't know they have it. Type 2 diabetes can wreak havoc on the entire body, affecting everything from ...

and more »

See the original post here:
Patient Voices: Type 2 Diabetes - New York Times

Posted in Diabetes | Comments Off on Patient Voices: Type 2 Diabetes – New York Times

JDRF works to raise Type 1 diabetes awareness – Clearfield Progress

Posted: March 14, 2017 at 2:46 pm

Some people believe they are healthy as horses, work out like fiends and run marathons or lift 500 pounds. However, here is a sobering message:

Those people are at the same risk of getting Type 1 diabetes as the not-so-fit folks who consider a short walk quality exercise. Type 1 diabetes doesnt care who it attacks. It can be a model, movie star, athlete or couch potato.

The Illinois Chapter of the Juvenile Diabetes Research Foundation is spending most of spring and summer preparing for huge fall and winter events, and during this relative down time, the group is trying to get the word out to as many people as possible that Type 1 diabetes is not just affecting juveniles any more. According to Illinois JDRF Director of Corporate and Marketing Partnerships Dana Snodgrass, 1.25 million people have Type 1, and its not just kids.

Unfortunately, its a growing disease and there is nothing you can do to prevent it, she says. Its not like its caused by you eating unhealthy foods or you are not exercising or you are overweight. You are born with it and you can be diagnosed with it at any age.

Now people are being diagnosed when they are 30, 40 and 50 years old. In the past, if you were an adult with Diabetes, you were diagnosed as Type 2. But now, more people are finding out its actually Type 1. You might be 50 years old, but for some reason, your body just stopped producing insulin. You had it all along.

Snodgrass says if its not diagnosed, the worst-case scenario could be a diabetic coma that can result in death.

If you see someone, you might not be able to tell they even have it, she says. Its something you have the rest of your life and its difficult to maintain. I dont think enough people know about it.

Another project for JDRF is the yearlong Bag of Hope program in which kids who are diagnosed with Type 1 learn about how to live with the disease. A teddy bear with Diabetes, Rufus, helps to get children through this ordeal.

There are books, measuring cups and a lot of other resources for children with Type 1, Snodgrass says. In Illinois, we partner with hospitals and physicians offices, and children and parents receive these Bags of Hope. It helps them after their first couple of days.

Once you are diagnosed, your entire life changes. You have to learn what you can eat and when you can eat it, how to give yourself injections, monitoring your blood. You are usually in the hospital for three days and you have all the resources there. Then you go home and all of this becomes the new normal. Its earthshattering. This bag is for the kids and parents to walk them through what needs to be done now that they are out of the hospital.

Later in the year, JDRF will host walkson September 24 and October 1that will celebratethe event's38th year and, in the past, have attracted 30,000-32,000 people per year.

Originally posted here:
JDRF works to raise Type 1 diabetes awareness - Clearfield Progress

Posted in Diabetes | Comments Off on JDRF works to raise Type 1 diabetes awareness – Clearfield Progress

Program offers help managing diabetes – Gaston Gazette

Posted: March 14, 2017 at 2:46 pm

From staff reports

Do you or a family member have diabetes and on Medicare? If so, then learn to take control of your diabetes with the upcoming "Living Healthy with Diabetes" workshop.

NC Cooperative Extension is offering the next session of theworkshop, a free self-management program which begins in May. This particular workshop is especially designed for Medicare Part B recipients (ages 65 and older) who have been diagnosed with diabetes. These individuals will be eligible for one-on-one nutrition counseling with a registered dietitian.

Were excited to be able to offer more personalized services with this session of Living Healthy with Diabetes , said Linda Minges, program facilitator for Gaston Extension. "Individuals who qualify for nutrition counseling with the dietitian will learn from other individuals with diabetes, as well as get personalized help with meal planning."

"Living Healthy with Diabetes" is a Stanford University program designed for anyone with diabetes, pre-diabetes, or at risk for diabetes. Participants will learn how to prevent low blood sugar; prevent and delay complications of diabetes; eat well; use medications effectively; manage pain, fatigue and depression; solve problems and set goals. The program is valued at more than $400 and there is no cost to participants.

'Living Healthy with Diabetes' truly makes a difference in the lives of so many people," said Minges. "Many participants report how helpful the group discussions are as well as being able to problem-solve together on health issues that impact everyone.

The program consists of six weekly sessions, scheduled for Wednesdays, May 10 through June 14 from 9 to11:30 a.m. All sessions will be held at the Lucile Tatum Center,959 Osceola St., Gastonia. There is no cost, but pre-registration is required. Participantsmust be able to attend at least four out of the six sessions. Participants receive a copy of Living a Healthy Life with Chronic Conditions workbook, a relaxation CD, tote bag, and refreshments. Pre-registration is required by contacting Linda J. Minges at 704-922-2127 or linda_minges@ncsu.edu before April 19. This program is supported by Centralina Area Agency on Aging.

Read the original:
Program offers help managing diabetes - Gaston Gazette

Posted in Diabetes | Comments Off on Program offers help managing diabetes – Gaston Gazette

3-D visualization of the pancreasnew tool in diabetes research – Medical Xpress

Posted: March 14, 2017 at 2:46 pm

March 14, 2017 The three-dimensional visualization, created with OPT, shows the pancreas of a healthy mouse. The individual pancreatic islets have been color-coded and their exact volume and 3-D-coordinates can be precisely determined throughout the pancreas. The exocrine pancreatic tissue (in grey) has partly been digitally removed. Credit: Ulf Ahlgren.

Ume researchers have created datasets that map the three-dimensional distribution and volume of the insulin-producing cells in the pancreas. The wealth of visual and quantitative information may serve as powerful reference resource for diabetes researchers. The Ume University researchers are now publishing their datasets in Scientific Data.

The hormone insulinwhich is needed to regulate the blood sugar levels of the bodyis produced by the pancreas and plays a key role in the development of diabetes. Insulin-producing cells are organised in the so-called Islets of Langerhans (or pancreatic islets), which are scattered by the thousands in the pancreas. In diabetes research, it is often important to study the quantity and distribution of insulin-producing cells. At present, such studies are generally based upon analyses of chosen cross-sections of pancreatic tissue. These in turn form the basis for attempting to gain an overall picture of the pancreas.

"However, such analyses only provide limited information and are often ridden with relatively large margins of error since the conclusions are based only on two-dimensional data," says Ulf Ahlgren, professor in molecular medicine at Ume University and in charge of the publications.

Ulf Ahlgren and his research colleagues at the Ume Centre for Molecular Medicine (UCMM) have previously developed new methods to create three-dimensional images of the insulin cell distribution in intact pancreas based on so-called optical projection tomography (OPT). This technique in many ways bears resemblance to a medical CT scanner, but instead of x-rays it uses regular light.

"We believe that the current publication represents the most comprehensive anatomical and quantitative description of the insulin cell distribution in the pancreas. By making these datasets accessible to other researchers, the data will be available for use as a powerful tool for a great number of diabetes studies. Examples may include planning of stereological analyses, in the development of non-invasive imaging techniques or various types of computational modelling and statistical analyses," says Ulf Ahlgren.

The video will load shortly

The datasets now published in Scientific Data consist of tomographic and 3D images. The datasets also include information on the individual volume of the Islets of Langerhans and their 3D coordinates and appearance throughout the entire pancreas in both healthy mice and obese mice (ob/ob), at different ages. The obese mice used in the study have a mutation that make them prone to develop obesity and diabetes.

The datasets highlight that islets differ in size and quantity within, and between, the various lobes of the pancreas. According to the research team, this emphasises that the pancreas should not be seen as a homogenous organ when experimental diabetes researchers study the insulin-producing Islets of Langerhans.

Visualising changes in the Islets of Langerhans

The datasets presented in Scientific Data form the basis of another recently published study in Scientific Reports. In that study, the researchers used the 3D data to identify changes in the Islets of Langerhans in the obese (ob/ob) mice. This animal model is often used to study initial metabolic changes that can lead to the development of type 2 diabetes. With the help of their refined techniques, the researchers could show that these mice to a great extent develop lesions in the Islets of Langerhans, manifesting as cyst-like structures. The study shows that these lesions are caused by internal bleeding as a consequence of an increased blood flow and instability of the blood vessels.

"Obese (ob/ob) mice have been described in thousands of publications. But the large prevalence of such internal islet lesions have never before been identified and visualised," says Ulf Ahlgren.

The researchers now want to study if similar intra-islet lesions also form in other models of type 2 diabetes and in humans, and if these may contribute to the diabetic phenotype.

Explore further: Lesions found within pancreatic islets provide clue for diabetes research

More information: Scientific Data, dataset: Spatial and quantitative datasets of the pancreatic -cell mass distribution in lean and obese mice. Authors: Saba Parween, Maria Eriksson, Christoffer Nord, Elena Kostromina and Ulf Ahlgren. DOI: 10.1038/sdata.2017.31

Scientific Reports, article: Intra-islet lesions and lobular variations in -cell mass expansion in ob/ob mice revealed by 3D imaging of intact pancreas. Authors: Saba Parween, Elena Kostromina, Christoffer Nord, Maria Eriksson, Per Lindstrm and Ulf Ahlgren. DOI: 10.1038/srep34885

Dryad Digital Repository, datasets from: Spatial and quantitative datasets of the pancreatic -cell mass distribution in lean and obese mice. Authors: Parween S, Eriksson M, Nord C, Kostromina E, Ahlgren U. DOI: 10.5061/dryad.pk8dv

Journal reference: Scientific Reports

Provided by: Umea University

Researchers at the Ume Center for Molecular Medicine have created the first 3D spatial visualization of an obese mouse pancreas showing the distribution dynamics of insulin producing beta cells. The results show significant ...

Pulses of the sugar glucose can restore normal insulin release in mouse pancreas cells that have been exposed to excess glucose, according to a study published in PLOS Computational Biology. This finding could improve understanding ...

Professor Ulf Ahlgren and associates at Umea University in Sweden are a leading research team in the world in the development of optical projection tomography. With the aid of this imaging technology, they have now described ...

(Medical Xpress) -- Research from Karolinska Institutet shows that insulin secretion in the pancreas is not under direct neural control, as has previously been thought. The few nerves that are present are connected to blood ...

Diabetes researchers at Sweden's Karolinska Institutet have developed a novel technique that makes it possible to monitor insulin resistance in a non-invasive manner over time in mice. The new method, presented in the journal ...

Researchers at Karolinska Institutet in Sweden have found an innovative way to study glucose regulation in the body: by transferring the vital insulin-producing cells from the pancreas to the eye, the latter can serve as ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Link:
3-D visualization of the pancreasnew tool in diabetes research - Medical Xpress

Posted in Diabetes | Comments Off on 3-D visualization of the pancreasnew tool in diabetes research – Medical Xpress

Going gluten-free might actually increase your risk of diabetes – Men’s Fitness

Posted: March 14, 2017 at 2:46 pm


Bel Marra Health
Going gluten-free might actually increase your risk of diabetes
Men's Fitness
But those people who mistakenly think that going gluten-free is healthier may end up with higher risk of developing type-2 diabetes, say the researchers. Their study, which analyzed almost 200,000 people from three long-term studies and 4.24 million ...
Type 2 diabetes linked to low gluten dietsBel Marra Health
Could Going Gluten Free Raise Your Risk Of Diabetes?Coach

all 9 news articles »

See the original post here:
Going gluten-free might actually increase your risk of diabetes - Men's Fitness

Posted in Diabetes | Comments Off on Going gluten-free might actually increase your risk of diabetes – Men’s Fitness

NAS Issues Report on Preparing for Future Products of Biotechnology: National Academies of Sciences, Engineering … – The National Law Review

Posted: March 13, 2017 at 8:44 pm

On March 9, 2017, the National Academies of Sciences, Engineering, and Medicine (NAS) announced the release (pre-publication version) of a new report:Preparing for Future Products of Biotechnology.Pursuant to the White House Office of Science and Technology Policy's (OSTP) July 2, 2015, memorandum, Modernizing the Regulatory System for Biotechnology Products, NAS was tasked with looking into the future and describing the possible future products of biotechnology that will arise over the next five to ten years, as well as providing some insights that can help shape the capabilities within the agencies as they move forward.

Via an ad hoc committee, the Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System, NAS developed this report through several months of gathering and synthesizing information from several sources, including: 74 speakers over the course of three in-person meetings and eight webinars, including one presented by Lynn L. Bergeson; responses to its request for information from a dozen federal agencies; statements solicited from members of the public at its in-person meetings; written comments through the duration of the study; and recent NAS studies related to future products of biotechnology.

The report presents conclusions concerning the future biotechnology products themselves, as well the challenges that federal agencies will face in regulating them, which include:

The bioeconomy is growing rapidly and the U.S. regulatory system needs to provide a balanced approach for consideration of the many competing interests in the face of this expansion;

The profusion of biotechnology products over the next five to ten years has the potential to overwhelm the U.S. regulatory system, which may be exacerbated by a disconnect between research in regulatory science and expected uses of future biotechnology products;

Regulators will face difficult challenges as they grapple with a broad array of new types of bio-technology products -- for example, cosmetics, toys, pets, and office supplies -- that go beyond contained industrial uses and traditional environmental release;

The safe use of new biotechnology products requires rigorous, predictable, and transparent risk-analysis processes whose comprehensiveness, depth, and throughput mirror the scope, scale, complexity, and tempo of future biotechnology applications.

The report provides three recommendations for federal agencies in responding to these challenges, which it states should be taken to enhance the ability of the biotechnology regulatory system to oversee the consumer safety and environmental protection required for future biotechnology products:

The U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), and other agencies involved in regulation of future bio-technology products should increase scientific capabilities, tools, expertise, and horizon scanning in key areas of expected growth of biotechnology, including natural, regulatory, and social sciences.

EPA, FDA, and USDA should increase their use of pilot projects to advance understanding and use of ecological risk assessments and benefit analyses for future biotechnology products that are unfamiliar and complex and to prototype new approaches for iterative risk analyses that incorporate external peer review and public participation.

The National Science Foundation, the Department of Defense, the Department of Energy, the National Institute of Standards and Technology, and other agencies that fund bio-technology research with the potential to lead to new biotechnology products should increase their investments in regulatory science and link research and education activities to regulatory-science activities.

The report is well-written and contains an impressive amount of new, relevant, and important information. The Committee participants are to be commended for an important new piece of scholarship in this area.

The reports conclusions are also significant, but not entirely unexpected.For those of us working in this space, we have recognized for years the lack of clarity regarding jurisdictional boundaries, the paucity of government resources, and the urgent need for regulatory clarity and significantly enhanced funding. Unfortunately, given current Trump Administration efforts to diminish government funding for EPA, FDA, and elsewhere, the well-crafted and spot-on recommendations may tragically fall on deaf ears.Shareholders should carefully review the report and work hard to ensure the recommendations are implemented. The consequences of failing to increase scientific capabilities, tools, expertise, and horizon scanning in key areas of expected growth of biotechnology, including natural regulatory, and social sciences -- the number one recommendation in the report -- are too great to ignore.

2017 Bergeson & Campbell, P.C.

See original here:
NAS Issues Report on Preparing for Future Products of Biotechnology: National Academies of Sciences, Engineering ... - The National Law Review

Posted in Biotechnology | Comments Off on NAS Issues Report on Preparing for Future Products of Biotechnology: National Academies of Sciences, Engineering … – The National Law Review

Puma Biotechnology Inc (PBYI) Moves Higher on Volume Spike for March 13 – Equities.com

Posted: March 13, 2017 at 8:44 pm

Market Summary Follow

Puma Biotechnology Inc is a A biopharmaceutical company

PBYI - Market Data & News

PBYI - Stock Valuation Report

Puma Biotechnology Inc (PBYI) traded on unusually high volume on Mar. 13, as the stock gained 11.86% to close at $44.80. On the day, Puma Biotechnology Inc saw 1.88 million shares trade hands on 13,031 trades. Considering that the stock averages only a daily volume of 1.15 million shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $73.27 and $19.74 over the last 52-weeks, its 50-day SMA is now $34.81, and its 200-day SMA $42.33. Puma Biotechnology Inc has a P/B ratio of 7.89.

Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care.

Headquartered in Los Angeles, CA, Puma Biotechnology Inc has 160 employees and is currently under the leadership of CEO Alan H. Auerbach.

For a complete fundamental analysis analysis of Puma Biotechnology Inc, check out Equities.coms Stock Valuation Analysis report for PBYI.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investments Market Commentary and Adam Sarhans Find Leading Stocks today.

To get more information on Puma Biotechnology Inc and to follow the companys latest updates, you can visit the companys profile page here: PBYIs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

The rest is here:
Puma Biotechnology Inc (PBYI) Moves Higher on Volume Spike for March 13 - Equities.com

Posted in Biotechnology | Comments Off on Puma Biotechnology Inc (PBYI) Moves Higher on Volume Spike for March 13 – Equities.com

Portugal to support Nigeria in Biotechnology activities – TV360 Nigeria – TV360

Posted: March 13, 2017 at 8:44 pm

The Portuguese Minister of Science and Technology, Manuel Heitor, say his country will offer technical support to Nigeria in key biotechnology activities that will enhance tropical agriculture and food security.

Heitor made this known in a statement made available to the News Agency of Nigeria (NAN) by the Head, Protocol and Communications, National Biotechnology Development Agency (NABDA), Ifeoma Ndefo on Monday in Abuja.

The minister visited the Director-General, National Biotechnology Development Agency (NABDA), LucyOgbadu, with a team of experts in different fields of biotechnology from various institutions in Portugal.

In his address, Heitor indicated interest of the Portuguese delegation in partnering with the NABDA on efforts to expand technologies that would enhance tropical agriculture and food security.

The minister,who is also the minister of Education, declared the interest of his country in assisting NABDA scientific officers wishing to acquire Masters and P.HD degrees in Portugal.

He identified areas of NABDAs activities akin to their fields of competencessuch as cancer prevention, stem cell research, Biogas production (converting wastes to generate electricity) and bio-remediation.

Heitor said all of thesewere areas of interest for collaboration as well as knowledge sharing between their institutions and NABDA.

On her part, Director-General, NABDA, commended the minister and his team for their interest to partner with the Agency and to ensure that Nigeria reaps the potential benefit that biotechnology offers.

The NABDA boss highlighted the various projects and activities of the five technical departments of the Agency.

This included the six Centres of Excellence located at frontline universities of the each of the Six Geo-political Zones of the nation (Uni-Jos, ABU Zaria, Uni- Port, UNN, Uni-Ibadan and Uni- Maiduguri).

Others are the NABDAs Bioresources Centres (BioDecs) spread across twenty-five states of the federation.

The News Agency of Nigeria recalls that the agency was established by the Federal Government to implement policy aimed at promoting, coordinating, and setting research and development priority in biotechnology for Nigeria.

NAN.

The rest is here:
Portugal to support Nigeria in Biotechnology activities - TV360 Nigeria - TV360

Posted in Biotechnology | Comments Off on Portugal to support Nigeria in Biotechnology activities – TV360 Nigeria – TV360

Page 1,642«..1020..1,6411,6421,6431,644..1,6501,660..»